CYP cynata therapeutics limited

Ann: Further GvHD Clinical Data Published in Nature Medicine, page-9

  1. 9,345 Posts.
    lightbulb Created with Sketch. 8004
    Indeed, the first Nature peer-reviewed article for those unfamiliar:

    https://www.nature.com/articles/s41591-020-1050-x

    Funny how these companies go undiscovered by most investors, disinterested until suddenly they aren't anymore. A bit of a watershed moment, and yes that might be OA results as far out as 2026, but then investors en-masse are like "how did we miss this? Its already multi-phased trialled and various academic institutions onboard."

    Pricing of information discovery at this end of the market is crap - which presents future opportunities for the patient and informed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
-0.005(2.86%)
Mkt cap ! $38.41M
Open High Low Value Volume
17.5¢ 17.5¢ 17.0¢ $42.82K 247.5K

Buyers (Bids)

No. Vol. Price($)
4 141820 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 58088 1
View Market Depth
Last trade - 14.00pm 07/08/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.